The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
How Is The Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market’s Market Value Anticipated To Evolve From 2026 To 2030?
The topical drugs contract development and manufacturing organization (cdmo) market has experienced rapid growth in recent years. It is anticipated to expand from $61.16 billion in 2025 to $70.96 billion in 2026, at a compound annual growth rate (CAGR) of 16.0%. This historical expansion can be attributed to increased pharmaceutical outsourcing, a growing prevalence of dermatological conditions, efforts by pharmaceutical companies toward cost optimization, an increase in regulatory complexity, and the expansion of generic topical drugs.
The topical drugs contract development and manufacturing organization (cdmo) market size is expected to see rapid growth in the next few years. It will grow to $121.22 billion in 2030 at a compound annual growth rate (CAGR) of 14.3%. The growth in the forecast period can be attributed to increasing development of advanced topical therapies, rising demand for transdermal patches, expansion of small and mid-sized pharma pipelines, growing need for scalable manufacturing, increased focus on speed to market. Major trends in the forecast period include rising outsourcing of topical drug manufacturing, growing demand for complex topical formulations, expansion of transdermal drug delivery platforms, increasing focus on regulatory-compliant manufacturing, higher demand for end-to-end CDMO services.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15942&type=smp
What Are The Main Drivers Accelerating The Growth Of The Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market?
The rising occurrence of skin conditions is anticipated to drive expansion in the topical drugs contract development and manufacturing organization (CDMO) market moving forward. These conditions are defined as medical ailments impacting the skin, manifesting symptoms like inflammation, itching, and lesions. The growing incidence of skin illnesses can be linked to elements including environmental pollution, UV radiation exposure, genetic predisposition, lifestyle changes, and microbial infections. The topical drugs contract development and manufacturing organization (CDMO) assists in mitigating the frequency of skin diseases through the creation and production of specific treatments designed to enhance the management and treatment of dermatological conditions. As an illustration, in 2023, data from Cancer Australia, an Australia-based government agency, indicated that around 8,257 new diagnoses of melanoma of the skin were recorded, contributing to 2.6% of all deaths from cancer. Consequently, the growing frequency of skin diseases is fueling the expansion of the topical drugs contract development and manufacturing organization (CDMO) market.
How Are Different Segment Groups Identified Within The Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market?
The topical drugs contract development and manufacturing organization (cdmo) market covered in this report is segmented –
1) By Product Type: Semi-Solid Formulations, Liquid Formulations Drugs, Solid Formulations, Transdermal Products
2) By Service Type: Contract Development, Contract Manufacturing
3) By Therapeutic Area: Dermatology, Pain Management, Wound Care, Ophthalmology, Other Therapeutic Areas
4) By End-Use: Pharmaceutical Companies, Biopharmaceutical Companies, Other End-Uses
Subsegments:
1) By Semi-Solid Formulations: Creams, Ointments, Gels, Pastes
2) By Liquid Formulations Drugs: Solutions, Suspensions, Emulsions, Lotions
3) By Solid Formulations: Powders
4) By Transdermal Products: Patches
Which Trends Are Expected To Shape The Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market?
Leading entities within the topical drugs contract development and manufacturing organization (CDMO) market are concentrating on establishing advanced manufacturing sites to maintain their competitive standing. Such cutting-edge facilities are specialized production locations featuring the newest technology and sophisticated processes specifically designed for producing and developing topical pharmaceutical items. An example of this is SOHM Inc., a US-based pharmaceutical firm, which inaugurated a CDMO GMP manufacturing facility in November 2023. This new Carlsbad site is designed to provide substantial area for both the production of topical goods and SOHM’s activities, including 2,500 square feet allocated for the storage of completed products. Initially, its daily production capability for topicals will be 500 gallons (1,892 liters). Plans project an expansion of this capacity to encompass soft-gel suppositories by the conclusion of Q1 2024 or the commencement of Q2 2024.
Which Industry Players Are Present In The Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market?
Major companies operating in the topical drugs contract development and manufacturing organization (cdmo) market are Catalent Inc., Lonza Group AG, Recipharm AB, Piramal Pharma Solutions, Cambrex Corporation, PCI Pharma Services, Famar S.A., Contract Pharmaceuticals Limited, UPM Pharmaceuticals Inc., MedPharm Ltd, Tergus Pharma LLC, NextPharma Technologies Holding Limited, Bora Pharmaceuticals Co. Ltd., LTS Lohmann Therapie-Systeme AG, CoreRx Inc., Halo Pharmaceutical Inc., Tapemark Company, Groupe PARIMA Inc., Dow Development Laboratories LLC, Tedor Pharma Inc.
Access The Complete Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Report:
Which Region Commands The Largest Share Of The Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market?
Asia-Pacific was the largest region in the topical drugs contract development and manufacturing organization (CDMO) market in 2025. The regions covered in the topical drugs contract development and manufacturing organization (cdmo) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/sample.aspx?id=15942&type=smp
Browse Through More Reports Similar to the Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market 2026, By The Business Research Company
Topical Drugs Contract Development And Manufacturing Organization Cdmo Market Report 2026
Pharmaceutical Contract Developments And Manufacturing Organization Cmo Market Report 2026
Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization Cdmo Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model